title: Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2.
authors.affiliation: Department of Clinical Pharmacology, Flinders Medical Centre, Adelaide, Australia.
authors.forename: W
authors.initials: W
authors.lastname: Tassaneeyakul
authors.forename: D J
authors.initials: DJ
authors.lastname: Birkett
authors.forename: M E
authors.initials: ME
authors.lastname: Veronese
authors.forename: M E
authors.initials: ME
authors.lastname: McManus
authors.forename: R H
authors.initials: RH
authors.lastname: Tukey
authors.forename: J O
authors.initials: JO
authors.lastname: Miners
mesh_terms: D000818:Animals; D002460:Cell Line; D019388:Cytochrome P-450 CYP1A2; D065607:Cytochrome P-450 Enzyme Inhibitors; D006801:Humans; D007700:Kinetics; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D065607:Cytochrome P-450 Enzyme Inhibitors; D013806:Theophylline; C050131:furafylline; D010088:Oxidoreductases; D019388:Cytochrome P-450 CYP1A2